{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:48:25Z","timestamp":1794433705266,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR080902"],"award-info":[{"award-number":["AR080902"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR083662"],"award-info":[{"award-number":["AR083662"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR080902"],"award-info":[{"award-number":["AR080902"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Eng"],"DOI":"10.1186\/s13036-025-00519-7","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T13:08:45Z","timestamp":1747660125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Dual-responsive synthetic gene circuit for dynamic biologic drug delivery via inflammatory and circadian signaling pathways"],"prefix":"10.1186","volume":"19","author":[{"given":"Amanda","family":"Cimino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Pat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omolabake","family":"Oyebamiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine T.N.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik D.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshid","family":"Guilak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"519_CR1","doi-asserted-by":"crossref","unstructured":"Nims RJ et al. A synthetic mechanogenetic gene circuit for autonomous drug delivery in engineered tissues. Sci Adv 7 (2021).","DOI":"10.1126\/sciadv.abd9858"},{"key":"519_CR2","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1089\/ten.tea.2019.0027","volume":"25","author":"L Pferdehirt","year":"2019","unstructured":"Pferdehirt L, Ross AK, Brunger JM, Guilak F. A synthetic gene circuit for Self-Regulating delivery of biologic drugs in engineered tissues. Tissue Eng Part A. 2019;25:809\u201320.","journal-title":"Tissue Eng Part A"},{"key":"519_CR3","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41467-025-56584-5","volume":"16","author":"L Pferdehirt","year":"2025","unstructured":"Pferdehirt L, et al. A synthetic chronogenetic gene circuit for programmed circadian drug delivery. Nat Commun. 2025;16:1457.","journal-title":"Nat Commun"},{"key":"519_CR4","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.stemcr.2017.03.022","volume":"8","author":"JM Brunger","year":"2017","unstructured":"Brunger JM, Zutshi A, Willard VP, Gersbach CA, Guilak F. Genome engineering of stem cells for autonomously regulated, Closed-Loop delivery of biologic drugs. Stem Cell Rep. 2017;8:1202\u201313.","journal-title":"Stem Cell Rep"},{"key":"519_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ymthe.2016.10.005","volume":"25","author":"A Smole","year":"2017","unstructured":"Smole A, Lainscek D, Bezeljak U, Horvat S, Jerala R. A synthetic mammalian therapeutic gene circuit for sensing and suppressing inflammation. Mol Ther. 2017;25:102\u201319.","journal-title":"Mol Ther"},{"key":"519_CR6","doi-asserted-by":"publisher","first-page":"318ra201","DOI":"10.1126\/scitranslmed.aac4964","volume":"7","author":"L Schukur","year":"2015","unstructured":"Schukur L, Geering B, Charpin-El Hamri G, Fussenegger M. Implantable synthetic cytokine converter cells with AND-gate logic treat experimental psoriasis. Sci Transl Med. 2015;7:318ra201.","journal-title":"Sci Transl Med"},{"key":"519_CR7","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","volume":"402","author":"A Di Matteo","year":"2023","unstructured":"Di Matteo A, Bathon JM, Emery P. Rheumatoid arthritis. Lancet. 2023;402:2019\u201333.","journal-title":"Lancet"},{"key":"519_CR8","first-page":"1602","volume":"30","author":"AM Selvaag","year":"2003","unstructured":"Selvaag AM, et al. Measuring health status in early juvenile idiopathic arthritis: determinants and responsiveness of the child health questionnaire. J Rheumatol. 2003;30:1602\u201310.","journal-title":"J Rheumatol"},{"key":"519_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12519-018-0212-0","volume":"16","author":"S Jeamsripong","year":"2020","unstructured":"Jeamsripong S, Charuvanij S. Features distinguishing juvenile idiopathic arthritis among children with musculoskeletal complaints. World J Pediatr. 2020;16:74\u201381.","journal-title":"World J Pediatr"},{"key":"519_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12969-021-00629-8","volume":"19","author":"LN Zaripova","year":"2021","unstructured":"Zaripova LN, et al. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol Online J. 2021;19:135.","journal-title":"Pediatr Rheumatol Online J"},{"key":"519_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/03009742.2011.566433","volume":"125","author":"S Sierakowski","year":"2011","unstructured":"Sierakowski S, Cutolo M. Morning symptoms in rheumatoid arthritis: a defining characteristic and marker of active disease. Scand J Rheumatol Suppl. 2011;125:1\u20135.","journal-title":"Scand J Rheumatol Suppl"},{"key":"519_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3899\/jrheum.121521","volume":"41","author":"VP Bykerk","year":"2014","unstructured":"Bykerk VP, et al. Flares in rheumatoid arthritis: frequency and management. A report from the BRASS registry. J Rheumatol. 2014;41:227\u201334.","journal-title":"J Rheumatol"},{"key":"519_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","volume":"82","author":"JS Smolen","year":"2023","unstructured":"Smolen JS, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82:3\u201318.","journal-title":"Ann Rheum Dis"},{"key":"519_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13075-019-1815-0","volume":"21","author":"EC de Moel","year":"2019","unstructured":"de Moel EC, et al. In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response. Arthritis Res Ther. 2019;21:28.","journal-title":"Arthritis Res Ther"},{"key":"519_CR15","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.amjmed.2014.06.012","volume":"127","author":"TL Michaud","year":"2014","unstructured":"Michaud TL, Rho YH, Shamliyan T, Kuntz KM, Choi HK. The comparative safety of tumor necrosis factor inhibitors in rheumatoid arthritis: a meta-analysis update of 44 trials. Am J Med. 2014;127:1208\u201332.","journal-title":"Am J Med"},{"key":"519_CR16","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.3899\/jrheum.141520","volume":"42","author":"TM Kuijper","year":"2015","unstructured":"Kuijper TM, Lamers-Karnebeek FB, Jacobs JW, Hazes JM, Luime JJ. Flare rate in patients with rheumatoid arthritis in low disease activity or remission when tapering or stopping synthetic or biologic DMARD: A systematic review. J Rheumatol. 2015;42:2012\u201322.","journal-title":"J Rheumatol"},{"key":"519_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13075-015-0730-2","volume":"17","author":"IM Markusse","year":"2015","unstructured":"Markusse IM, et al. Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the best study. Arthritis Res Ther. 2015;17:232.","journal-title":"Arthritis Res Ther"},{"key":"519_CR18","doi-asserted-by":"crossref","unstructured":"Fenton OS, Olafson KN, Pillai PS, Mitchell MJ, Langer R. Advances in biomaterials for drug delivery. Adv Mater, e1705328 (2018).","DOI":"10.1002\/adma.201705328"},{"key":"519_CR19","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s13346-021-00977-8","volume":"11","author":"Z Deng","year":"2021","unstructured":"Deng Z, Liu S. Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases. Drug Deliv Transl Res. 2021;11:1475\u201397.","journal-title":"Drug Deliv Transl Res"},{"key":"519_CR20","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1007\/s13346-024-01539-4","volume":"14","author":"CT Butler","year":"2024","unstructured":"Butler CT, Rodgers AM, Curtis AM, Donnelly RF. Chrono-tailored drug delivery systems: recent advances and future directions. Drug Deliv Transl Res. 2024;14:1756\u201375.","journal-title":"Drug Deliv Transl Res"},{"key":"519_CR21","doi-asserted-by":"publisher","first-page":"115325","DOI":"10.1016\/j.addr.2024.115325","volume":"209","author":"X An","year":"2024","unstructured":"An X, et al. Advances in local drug delivery technologies for improved rheumatoid arthritis therapy. Adv Drug Deliv Rev. 2024;209:115325.","journal-title":"Adv Drug Deliv Rev"},{"key":"519_CR22","doi-asserted-by":"publisher","unstructured":"Cimino A, Oyebamiji F, Pferdehirt O, Pham L, Herzog CTN, Guilak ED. F. Programmable chronogenetic gene circuits for self-regulated circadian delivery of biologic drugs. BioRxiv (2025). https:\/\/doi.org\/10.1101\/2025.03.14.643274.","DOI":"10.1101\/2025.03.14.643274"},{"key":"519_CR23","doi-asserted-by":"publisher","first-page":"eabj1414","DOI":"10.1126\/sciadv.abj1414","volume":"7","author":"YR Choi","year":"2021","unstructured":"Choi YR, et al. A genome-engineered bioartificial implant for autoregulated anticytokine drug delivery. Sci Adv. 2021;7:eabj1414.","journal-title":"Sci Adv"},{"key":"519_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/ar4146","volume":"15","author":"JE Gibbs","year":"2013","unstructured":"Gibbs JE, Ray DW. The role of the circadian clock in rheumatoid arthritis. Arthritis Res Ther. 2013;15:205.","journal-title":"Arthritis Res Ther"},{"key":"519_CR25","doi-asserted-by":"publisher","first-page":"R122","DOI":"10.1186\/ar3852","volume":"14","author":"S Haas","year":"2012","unstructured":"Haas S, Straub RH. Disruption of rhythms of molecular clocks in primary synovial fibroblasts of patients with osteoarthritis and rheumatoid arthritis, role of IL-1beta\/TNF. Arthritis Res Ther. 2012;14:R122.","journal-title":"Arthritis Res Ther"},{"key":"519_CR26","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/j.joca.2015.02.020","volume":"23","author":"B Guo","year":"2015","unstructured":"Guo B, et al. Catabolic cytokines disrupt the circadian clock and the expression of clock-controlled genes in cartilage via an NFsmall Ka, CyrillicB-dependent pathway. Osteoarthritis Cartilage. 2015;23:1981\u20138.","journal-title":"Osteoarthritis Cartilage"},{"key":"519_CR27","doi-asserted-by":"publisher","first-page":"19172","DOI":"10.1073\/pnas.1210422109","volume":"109","author":"BO Diekman","year":"2012","unstructured":"Diekman BO, et al. Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012;109:19172\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"519_CR28","doi-asserted-by":"crossref","unstructured":"Salmon P, Trono D. Production and titration of lentiviral vectors. Curr Protoc Hum Genet Chap. 12, Unit 12 10 (2007).","DOI":"10.1002\/0471142905.hg1210s54"},{"key":"519_CR29","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0748730416668898","volume":"31","author":"KA Feeney","year":"2016","unstructured":"Feeney KA, Putker M, Brancaccio M, O\u2019Neill JS. In-depth characterization of firefly luciferase as a reporter of circadian gene expression in mammalian cells. J Biol Rhythms. 2016;31:540\u201350.","journal-title":"J Biol Rhythms"},{"key":"519_CR30","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/ard.49.9.676","volume":"49","author":"CI Westacott","year":"1990","unstructured":"Westacott CI, et al. Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis. 1990;49:676\u201381.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"519_CR31","doi-asserted-by":"publisher","first-page":"i103","DOI":"10.1136\/ard.59.suppl_1.i103","volume":"59","author":"MH Schiff","year":"2000","unstructured":"Schiff MH. Role of Interleukin 1 and Interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis. Ann Rheum Dis. 2000;59(Suppl 1):i103\u2013108.","journal-title":"Ann Rheum Dis"},{"key":"519_CR32","doi-asserted-by":"publisher","first-page":"eabj8892","DOI":"10.1126\/sciadv.abj8892","volume":"8","author":"L Pferdehirt","year":"2022","unstructured":"Pferdehirt L, et al. Synthetic gene circuits for preventing disruption of the circadian clock due to interleukin-1-induced inflammation. Sci Adv. 2022;8:eabj8892.","journal-title":"Sci Adv"},{"key":"519_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.copbio.2017.06.011","volume":"47","author":"Y Higashikuni","year":"2017","unstructured":"Higashikuni Y, Chen WC, Lu TK. Advancing therapeutic applications of synthetic gene circuits. Curr Opin Biotechnol. 2017;47:133\u201341.","journal-title":"Curr Opin Biotechnol"},{"key":"519_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9","volume":"43","author":"JJ Anderson","year":"2000","unstructured":"Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum. 2000;43:22\u20139.","journal-title":"Arthritis Rheum"},{"key":"519_CR35","doi-asserted-by":"publisher","first-page":"l67","DOI":"10.1136\/bmj.l67","volume":"364","author":"JE Gottenberg","year":"2019","unstructured":"Gottenberg JE, et al. Comparative effectiveness of rituximab, abatacept, and Tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study. BMJ. 2019;364:l67.","journal-title":"BMJ"},{"key":"519_CR36","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/rheumatology\/ket416","volume":"53","author":"CA Flurey","year":"2014","unstructured":"Flurey CA, Morris M, Richards P, Hughes R, Hewlett S. It\u2019s like a juggling act: rheumatoid arthritis patient perspectives on daily life and flare while on current treatment regimes. Rheumatology (Oxford). 2014;53:696\u2013703.","journal-title":"Rheumatology (Oxford)"},{"key":"519_CR37","doi-asserted-by":"publisher","first-page":"rkac021","DOI":"10.1093\/rap\/rkac021","volume":"6","author":"J Gandrup","year":"2022","unstructured":"Gandrup J, Selby DA, van der Veer SN, McBeth J, Dixon WG. Using patient-reported data from a smartphone app to capture and characterize real-time patient-reported flares in rheumatoid arthritis. Rheumatol Adv Pract. 2022;6:rkac021.","journal-title":"Rheumatol Adv Pract"},{"key":"519_CR38","doi-asserted-by":"publisher","first-page":"R134","DOI":"10.1186\/ar4591","volume":"16","author":"BD Furman","year":"2014","unstructured":"Furman BD, et al. Targeting pro-inflammatory cytokines following joint injury: acute intra-articular Inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis. Arthritis Res Ther. 2014;16:R134.","journal-title":"Arthritis Res Ther"},{"key":"519_CR39","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cell.2016.01.011","volume":"164","author":"KT Roybal","year":"2016","unstructured":"Roybal KT, et al. Precision tumor recognition by T cells with combinatorial Antigen-Sensing circuits. Cell. 2016;164:770\u20139.","journal-title":"Cell"},{"key":"519_CR40","doi-asserted-by":"publisher","first-page":"L1056","DOI":"10.1152\/ajplung.00152.2015","volume":"309","author":"IK Sundar","year":"2015","unstructured":"Sundar IK, Yao H, Sellix MT, Rahman I. Circadian molecular clock in lung pathophysiology. Am J Physiol Lung Cell Mol Physiol. 2015;309:L1056\u20131075.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"519_CR41","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nm.3599","volume":"20","author":"J Gibbs","year":"2014","unstructured":"Gibbs J, et al. An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action. Nat Med. 2014;20:919\u201326.","journal-title":"Nat Med"},{"key":"519_CR42","doi-asserted-by":"crossref","unstructured":"Wang S et al. An NF-kappaB-driven LncRNA orchestrates colitis and circadian clock. Sci Adv 6 (2020).","DOI":"10.1126\/sciadv.abb5202"},{"key":"519_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.cell.2010.12.019","volume":"144","author":"M Ukai-Tadenuma","year":"2011","unstructured":"Ukai-Tadenuma M, et al. Delay in feedback repression by Cryptochrome 1 is required for circadian clock function. Cell. 2011;144:268\u201381.","journal-title":"Cell"},{"key":"519_CR44","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/ncb1775","volume":"10","author":"M Ukai-Tadenuma","year":"2008","unstructured":"Ukai-Tadenuma M, Kasukawa T, Ueda HR. Proof-by-synthesis of the transcriptional logic of mammalian circadian clocks. Nat Cell Biol. 2008;10:1154\u201363.","journal-title":"Nat Cell Biol"},{"key":"519_CR45","doi-asserted-by":"crossref","unstructured":"Collins KH et al. Hydrogel encapsulation of Genome-Engineered stem cells for Long-Term Self-Regulating Anti-Cytokine therapy. Gels 9 (2023).","DOI":"10.3390\/gels9020169"},{"key":"519_CR46","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/art.1780340112","volume":"34","author":"RJ Smith","year":"1991","unstructured":"Smith RJ, Chin JE, Sam LM, Justen JM. Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1-stimulated cartilage erosion and chondrocyte responsiveness. Arthritis Rheum. 1991;34:78\u201383.","journal-title":"Arthritis Rheum"},{"key":"519_CR47","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1172\/JCI114622","volume":"85","author":"WP Arend","year":"1990","unstructured":"Arend WP, Welgus HG, Thompson RC, Eisenberg SP. Biological properties of Recombinant human monocyte-derived Interleukin 1 receptor antagonist. J Clin Invest. 1990;85:1694\u20137.","journal-title":"J Clin Invest"},{"key":"519_CR48","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1165\/ajrcmb.20.5.3458","volume":"20","author":"KR Coulter","year":"1999","unstructured":"Coulter KR, Wewers MD, Lowe MP, Knoell DL. Extracellular regulation of Interleukin (IL)-1beta through lung epithelial cells and defective IL-1 type II receptor expression. Am J Respir Cell Mol Biol. 1999;20:964\u201375.","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Journal of Biological Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-025-00519-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13036-025-00519-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-025-00519-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T14:03:48Z","timestamp":1747663428000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbioleng.biomedcentral.com\/articles\/10.1186\/s13036-025-00519-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["519"],"URL":"https:\/\/doi.org\/10.1186\/s13036-025-00519-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.20.644403","asserted-by":"object"}]},"ISSN":["1754-1611"],"issn-type":[{"value":"1754-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FG is an employee and shareholder in Cytex Therapeutics, Inc. FG has filed intellectual property on topics related to the content of this study (US Patent App. 18\/284,487, 2024). The authors declare no other competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}